RU94010496A - Nootropic agent and medicinal composition of nootropic agent
- Google Patents
Nootropic agent and medicinal composition of nootropic agent
Info
Publication number
RU94010496A
RU94010496ARU94010496/14ARU94010496ARU94010496ARU 94010496 ARU94010496 ARU 94010496ARU 94010496/14 ARU94010496/14 ARU 94010496/14ARU 94010496 ARU94010496 ARU 94010496ARU 94010496 ARU94010496 ARU 94010496A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт молекулярной генетики РАНfiledCriticalИнститут молекулярной генетики РАН
Priority to RU94010496/14ApriorityCriticalpatent/RU2045958C1/en
Application grantedgrantedCritical
Publication of RU2045958C1publicationCriticalpatent/RU2045958C1/en
Publication of RU94010496ApublicationCriticalpatent/RU94010496A/en
FIELD: medicine, pharmacy. SUBSTANCE: invention proposes heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro as a nootropic agent. The proposed nootropic agent has heptapeptide (0.95-1.05 g/l) as an active component, preserving agent nipagin (0.9501.05 g/l) and distilled water - the rest. Agent is used as nasal drops. EFFECT: high effectiveness of agent at low doses, simplified use.
Claims (1)
Изобретение используется в медицине. Сущность изобретения: применение гептапептида Met-Glu-His-Phe-Pro-Gly-Pro в качестве ноотропного средства. Предложен новый состав ноотропного средства, содержащий активное вещество в виде гептапептида (0,95-1,05 г/л), консервант в виде нипагина (0,95-1,05 г/л) и вода дистиллированная остальное. Состав высокоэффективен в низких дозах и прост в применении: используется в виде капель в нос.The invention is used in medicine. The inventive use of the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro as a nootropic agent. A new composition of a nootropic agent is proposed, containing the active substance in the form of a heptapeptide (0.95-1.05 g / l), a preservative in the form of nipagin (0.95-1.05 g / l), and the rest is distilled water. The composition is highly effective in low doses and easy to use: used in the form of drops in the nose.
RU94010496/14A1994-03-281994-03-28Nootropic drug and pharmaceutical nootropic composition
RU2045958C1
(en)
PHARMACEUTICAL COMPOSITION NOT LIOFILIZED IN THE FORM OF A SOLUTION THAT INCLUDES HUMAN PARTIROID HORMONE, PROCESS TO PREPARE A FLASK OR CARTRIDGE CONTAINING IT, PROCESS TO PREPARE SUCH COMPOSITION, BOTTLE OR CARTRIDGE THAT CONTAINS THE COMPOSITION OF THE COMPOSITION OF THE COMPOSITION
Novel pharmaceutical composition for the preparation of a stable powder containing an active ingredient comprising a combination of acetylsalicylic acid and metoclopramide
PROCEDURE TO PRODUCE 1-B-D-ARABINOFURANOSILCITOSINA-5'-STERARILFOSFATO MONOSODICO AND MONOHIDRATO OF THE SAME, AND PHARMACEUTICAL COMPOUND THAT CONTAINS THIS LAST.